Bright Heart Health, a leading telemedicine opioid use disorder, substance abuse, and eating disorder treatment center headquartered in Northern California, today announced Dr. David Kan, MD as the new Medical Director of the national Rapid Access Opioid Use Disorder program. Dr. Kan is Board-Certified in General and Forensic Psychiatry and Board-Certified in Addiction Medicine. Dr. Kan will oversee medical procedures and policies to ensure patients receive effective, individualized, and kindhearted care.

“Dr. Kan brings deep expertise treating patients with buprenorphine in an outpatient setting,” said Jonathan Ciampi, Chief Executive Officer at Bright Heart Health. “We welcome Dr. Kan as our new Medical Director and look forward to his contributions as we continue to focus on providing the best healthcare in the industry. With the use of telemedicine and Dr. Kan’s leadership, Bright Heart Health is helping tackle the national opioid abuse epidemic by providing a national rapid access program to treat individuals abusing prescription pills and heroin.”

Dr. Kan graduated from Northwestern University Medical School and finished his General Psychiatry Residency and Forensic Psychiatry Fellowship at the University of California, San Francisco. He is Board-Certified by the American Board of Psychiatry and Neurology in General and Forensic Psychiatry and he is Board-Certified by the American Board of Addiction Medicine in Addiction Medicine. He has won multiple awards for teaching and clinical care delivery. He is a member of the faculty at the UCSF Department of Psychiatry where he teaches and supervises psychiatrists-in-training. Throughout the year, he speaks at professional conferences on topics including treatment of addictive disorder.

Dr. Kan offers forensic consulting services to courts and attorneys in civil, criminal, and administrative matters and is a member of the American Academy of Psychiatry and the Law. Dr. Kan has also worked at the San Francisco Veterans Administration Medical Center in the Department of Psychiatry since 2004. He has been the Associate Chief of Service for Quality Improvement and Assurance. He has maintained an active Forensic consulting practice since graduating from fellowship.

Dr. Kan is an active member of the California Society of Addiction Medicine (CSAM), a physician organization dedicated to improving the treatment of substance use disorders. Dr. Kan is the current President-Elect for CSAM. Dr. Kan was recently named a Distinguished Fellow of the American Society of Addiction Medicine (D.F.A.S.A.M.).

 To learn more, visit www.brighthearthealth.com.